Markets:

Overview

News

Currencies

International

Treasuries

RxSight, Inc. - Common Stock (NQ:RXST)

8.320 +0.280 (+3.48%)

Streaming Delayed Price Updated: 10:21 AM EST, Feb 17, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about RxSight, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

RXST Stock Earnings: RxSight Beats EPS, Beats Revenue for Q1 2024 ↗

May 06, 2024

RXST stock results show that RxSight beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 06, 2024

Via Benzinga

RxSight, Inc. Reports First Quarter 2024 Financial Results

May 06, 2024

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Present at the Bank of America Healthcare Conference

May 01, 2024

From RxSight, Inc.

Via GlobeNewswire

Assessing RxSight: Insights From 8 Financial Analysts ↗

April 11, 2024

Via Benzinga

Forecasting The Future: 9 Analyst Projections For RxSight ↗

February 29, 2024

Via Benzinga

Recap: RxSight Q4 Earnings ↗

February 28, 2024

Via Benzinga

RxSight's Earnings Outlook ↗

February 27, 2024

Via Benzinga

RxSight, Inc. to Report First Quarter Financial Results on May 6, 2024

April 22, 2024

From RxSight, Inc.

Via GlobeNewswire

RxSight Announces Commercial Launch of its Newest Light Adjustable Lens™, the LAL+™, and Features Multiple Doctor Presentations at the Upcoming ASCRS Annual Meeting

April 04, 2024

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Participate in the 23rd Annual Needham Virtual Healthcare Conference

March 27, 2024

From RxSight, Inc.

Via GlobeNewswire

Stifel Maintains Buy Rating for RxSight: Here's What You Need To Know ↗

February 12, 2024

Via Benzinga

The Analyst Landscape: 8 Takes On RxSight ↗

January 29, 2024

Via Benzinga

Breaking Down RxSight: 5 Analysts Share Their Views ↗

January 08, 2024

Via Benzinga

Chart Of The Day: RxSight - Cashing In On Cataracts ↗

March 04, 2024

Earnings are estimated to increase 33.30% this year, increase an additional 26.60% next year and continue to compound at an annual rate of 19.00% for the next 5 years

Via Talk Markets

RxSight, Inc. to Participate in the 34th Annual Oppenheimer Healthcare Conference

February 29, 2024

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

February 28, 2024

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024

February 14, 2024

From RxSight, Inc.

Via GlobeNewswire

Analyst Expectations for RxSight's Future ↗

December 13, 2023

Via Benzinga

RxSight: Q3 Earnings Insights ↗

November 09, 2023

Via Benzinga

Earnings Scheduled For February 28, 2024 ↗

February 28, 2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenue of $1.69 billion.

Via Benzinga

Insiders are selling these hot stocks on track for higher prices

February 07, 2024

Insiders are selling these hot stocks and may cap gains in the near term, but long-term gains are in the outlook. Analysts support them and raise their targets.

Via MarketBeat

Jim Cramer: This Healthcare Stock Is 'Too Risky,' But Shares Jumped 64% Over Past Month ↗

January 25, 2024

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Praxis Precision Medicines, Inc. (NASDAQ: PRAX) is "too risky."

Via Benzinga

3 Stocks to Buy BEFORE They Become Household Names ↗

January 12, 2024

The best way to find 100 baggers is to invest in undiscovered stock gems that have yet to become household names.

Via InvestorPlace

RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance

January 07, 2024

From RxSight, Inc.

Via GlobeNewswire

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

December 27, 2023

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. Reports Third Quarter 2023 Financial Results

November 09, 2023

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. Educational and Product Announcements for AAO 2023

November 02, 2023

From RxSight, Inc.

Via GlobeNewswire

RxSight, Inc. to Report Third Quarter Financial Results on November 9, 2023

October 26, 2023

From RxSight, Inc.

Via GlobeNewswire

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.